Guangdong Transtek Medical Electronics Past Earnings Performance
Past criteria checks 2/6
Guangdong Transtek Medical Electronics's earnings have been declining at an average annual rate of -14.9%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been declining at an average rate of 2.7% per year. Guangdong Transtek Medical Electronics's return on equity is 6.3%, and it has net margins of 6.8%.
Key information
-14.9%
Earnings growth rate
-18.0%
EPS growth rate
| Medical Equipment Industry Growth | 16.0% |
| Revenue growth rate | -2.7% |
| Return on equity | 6.3% |
| Net Margin | 6.8% |
| Next Earnings Update | 29 Mar 2025 |
Recent past performance updates
Recent updates
Market Might Still Lack Some Conviction On Guangdong Transtek Medical Electronics Co., Ltd (SZSE:300562) Even After 27% Share Price Boost
Dec 16
Guangdong Transtek Medical Electronics (SZSE:300562) Has Some Way To Go To Become A Multi-Bagger
Nov 25Guangdong Transtek Medical Electronics Co., Ltd (SZSE:300562) Stock Rockets 28% But Many Are Still Ignoring The Company
Aug 26Estimating The Fair Value Of Guangdong Transtek Medical Electronics Co., Ltd (SZSE:300562)
Apr 23Guangdong Transtek Medical Electronics' (SZSE:300562) Shareholders May Want To Dig Deeper Than Statutory Profit
Apr 01The Market Lifts Guangdong Transtek Medical Electronics Co., Ltd (SZSE:300562) Shares 36% But It Can Do More
Mar 08Revenue & Expenses Breakdown
How Guangdong Transtek Medical Electronics makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1,033 | 70 | 189 | 103 |
| 30 Jun 24 | 998 | 61 | 184 | 107 |
| 31 Mar 24 | 970 | 60 | 175 | 109 |
| 31 Dec 23 | 884 | 34 | 148 | 108 |
| 30 Sep 23 | 833 | -26 | 149 | 117 |
| 30 Jun 23 | 909 | -31 | 147 | 121 |
| 31 Mar 23 | 967 | -46 | 134 | 130 |
| 01 Jan 23 | 1,065 | -32 | 139 | 137 |
| 30 Sep 22 | 1,385 | -21 | 168 | 156 |
| 30 Jun 22 | 1,564 | -5 | 172 | 158 |
| 31 Mar 22 | 1,716 | -3 | 175 | 153 |
| 01 Jan 22 | 1,821 | 9 | 180 | 149 |
| 30 Sep 21 | 1,766 | 55 | 177 | 117 |
| 30 Jun 21 | 1,690 | 65 | 171 | 111 |
| 31 Mar 21 | 1,542 | 78 | 169 | 106 |
| 31 Dec 20 | 1,337 | 70 | 151 | 97 |
| 30 Sep 20 | 1,115 | 59 | 119 | 95 |
| 30 Jun 20 | 978 | 44 | 113 | 85 |
| 31 Mar 20 | 887 | 34 | 113 | 75 |
| 31 Dec 19 | 884 | 31 | 118 | 69 |
| 30 Sep 19 | 858 | 32 | 120 | 66 |
| 30 Jun 19 | 791 | 28 | 116 | 62 |
| 31 Mar 19 | 788 | 23 | 118 | 58 |
| 31 Dec 18 | 775 | 24 | 121 | 56 |
| 30 Sep 18 | 753 | 38 | 120 | 51 |
| 30 Jun 18 | 804 | 41 | 86 | 90 |
| 31 Mar 18 | 838 | 11 | 136 | 78 |
| 31 Dec 17 | 867 | 18 | 154 | 66 |
| 30 Sep 17 | 851 | 21 | 167 | 52 |
| 30 Jun 17 | 806 | 30 | 216 | 0 |
| 31 Mar 17 | 786 | 75 | 183 | 0 |
| 31 Dec 16 | 771 | 81 | 175 | 0 |
| 30 Sep 16 | 760 | 79 | 243 | 0 |
| 31 Mar 16 | 674 | 55 | 133 | 0 |
| 31 Dec 15 | 629 | 50 | 120 | 0 |
| 30 Sep 15 | 562 | 38 | 24 | 0 |
| 31 Mar 15 | 466 | 48 | 77 | 0 |
| 31 Dec 14 | 456 | 45 | 73 | 0 |
Quality Earnings: 300562 has high quality earnings.
Growing Profit Margin: 300562 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300562's earnings have declined by 14.9% per year over the past 5 years.
Accelerating Growth: 300562 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 300562 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-8.8%).
Return on Equity
High ROE: 300562's Return on Equity (6.3%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/03 08:33 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Guangdong Transtek Medical Electronics Co., Ltd is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Chunsheng Xie | Huatai Research |